Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CG Oncology, Inc. - Common stock (NQ: CGON )

42.23 -1.09 (-2.53%)
Streaming Delayed Price Updated: 10:34 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,708
Open 42.74
Bid (Size) 42.05 (4)
Ask (Size) 42.40 (4)
Prev. Close 43.32
Today's Range 41.62 - 43.68
52wk Range 28.55 - 50.23
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the Phase 3 BOND-003 trial at the 2024 AUA Annual Meeting 
From CG Oncology Inc.
Via GlobeNewswire
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
- Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC - 
From CG Oncology Inc.
Via GlobeNewswire

Performance

YTD
+6.49%
+6.49%
1 Month
-1.25%
-1.25%
3 Month
+14.12%
+14.12%
6 Month
+6.49%
+6.49%
1 Year
+6.49%
+6.49%

More News

Read More
IPO Stocks: Will Reddit Unplug The Bulging U.S. IPO Pipeline?
Via Investor's Business Daily
Topics Initial Public Offering
Exposures Securities Market
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
From CG Oncology Inc.
Via GlobeNewswire
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
From CG Oncology Inc.
Via GlobeNewswire
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
3 attractive stocks that insiders are buying
Via MarketBeat
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From CG Oncology, Inc.
Via Business Wire
KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.